These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25736676)

  • 1. Measles.
    Preston J
    Nurs Stand; 2015 Mar; 29(27):60. PubMed ID: 25736676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles resurgence in Belgium from January to mid-April 2011: a preliminary report.
    Sabbe M; Hue D; Hutse V; Goubau P
    Euro Surveill; 2011 Apr; 16(16):. PubMed ID: 21527134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of measles vaccination in HIV infected children].
    Ołdakowska A; Marczyńska M; Szczepańska-Putz M
    Przegl Epidemiol; 2001; 55(4):523-7. PubMed ID: 11921741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R; Rahman MM; Hassan Z; Hassan MS
    Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles in the United Kingdom 1990-2008 and the effectiveness of measles vaccines.
    Jick H; Hagberg KW
    Vaccine; 2010 Jun; 28(29):4588-92. PubMed ID: 20470793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the measles, mumps and rubella vaccination catch-up campaign in England in 2013.
    Simone B; Balasegaram S; Gobin M; Anderson C; Charlett A; Coole L; Maguire H; Nichols T; Rawlings C; Ramsay M; Oliver I
    Vaccine; 2014 Aug; 32(36):4681-8. PubMed ID: 24996125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of measles, mumps, and rubella vaccine in patients with DiGeorge syndrome.
    Al-Sukaiti N; Reid B; Lavi S; Al-Zaharani D; Atkinson A; Roifman CM; Grunebaum E
    J Allergy Clin Immunol; 2010 Oct; 126(4):868-9. PubMed ID: 20810153
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
    MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles: making a comeback?
    Nursing; 2010 Jul; 40(7):67. PubMed ID: 20548212
    [No Abstract]   [Full Text] [Related]  

  • 12. MMR vaccine: a new initiative.
    Miller C
    Practitioner; 1989 Jan; 233(1461):63-4, 66. PubMed ID: 2798287
    [No Abstract]   [Full Text] [Related]  

  • 13. Are parental vaccine safety concerns associated with receipt of measles-mumps-rubella, diphtheria and tetanus toxoids with acellular pertussis, or hepatitis B vaccines by children?
    Bardenheier B; Yusuf H; Schwartz B; Gust D; Barker L; Rodewald L
    Arch Pediatr Adolesc Med; 2004 Jun; 158(6):569-75. PubMed ID: 15184221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles and mumps immunity in Northern Greece, 2004-2007.
    Fylaktou A; Haidopoulou K; Goutaki M; Papadimitriou E; Kalamitsiou S; Papaventsis D
    Euro Surveill; 2008 Apr; 13(16):. PubMed ID: 18768118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report on the measles situation in Portugal.
    Gíria M; Rebelo-de-Andrade H; Fernandes T; Pedro S; Freitas G
    Euro Surveill; 2008 Oct; 13(42):. PubMed ID: 18926113
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.
    Böttiger M; Christenson B; Strandell A; Romanus V
    Dev Biol Stand; 1986; 65():37-43. PubMed ID: 3556776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles: the disease and its prevention.
    Bedford H
    Nurs Stand; 2003 Feb 26-Mar 4; 17(24):46-52; quiz 54-5. PubMed ID: 12655860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study.
    Mrozek-Budzyn D; Kiełtyka A; Majewska R
    Pediatr Infect Dis J; 2010 May; 29(5):397-400. PubMed ID: 19952979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.